Market Tracker

10/31 7:05pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.60
Data as of Oct 31
 +0.04 / +2.56%
Today’s Change
1.16
Today|||52-Week Range
3.18
+15.11%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close1.56
Today’s open1.56
Day’s range1.55 - 1.60
Volume807,322
Average volume (3 months)1,059,093
Market cap$280.0M
Dividend yield--
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-37.88%
Earnings growth (next 5 years)--
Revenue growth (last year)+3.31%
P/E ratioNM
Price/Sales12.55
Price/Book4.12

Competitors

 Today’s
change
Today’s
% change
AMBIAmbit Biosciences Co...+0.22+1.43%
POZNPOZEN Inc-0.10-1.09%
PRTKParatek Pharmaceutic...-4.40-21.57%
ADMSAdamas Pharmaceutica...-0.64-4.03%
Data as of 3:59pm ET, 10/31/2014

Financials

Next reporting dateDecember 11, 2014
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$22.4M
Annual profit (last year)-$35.4M
Net profit margin-157.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts